Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Gout × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1739 Neoplasms 1253 Carcinoma, Non-Small-Cell Lung 1132 Prostatic Neoplasms 938 Multiple Myeloma 725 Leukemia, Myeloid, Acute 650 Neoplasm Metastasis 613 Colorectal Neoplasms 607 Lung Neoplasms 591 Melanoma 576 Lymphoma 557 Leukemia 506 Lymphoma, Non-Hodgkin 487 Ovarian Neoplasms 457 Leukemia, Lymphocytic, Chronic, B-Cell 455 Pancreatic Neoplasms 434 Precursor Cell Lymphoblastic Leukemia-Lymphoma 412 Recurrence 400 Myelodysplastic Syndromes 357 Carcinoma, Renal Cell 355 Lymphoma, Follicular 354 Head and Neck Neoplasms 338 Glioblastoma 334 Brain Neoplasms 327 Lymphoma, Large B-Cell, Diffuse 317 Carcinoma, Hepatocellular 291 Hodgkin Disease 288 Squamous Cell Carcinoma of Head and Neck 267 Lymphoma, Mantle-Cell 262 Sarcoma 241

Interventions

Omeprazole 1 Naproxen 1 Febuxostat 1 Colchicine 1 Allopurinol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02500641 2019-06-21

FORWARD

Menarini International Operations Luxembourg SA

Phase 4 Completed

196 enrolled 9 charts

Arthritis, Cardiovascular Diseases, Gout, Inflammation, Hyperuricemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡